Unchained Labs is a Pleasanton, Calif.-based life sciences company that matches biologics researchers with laboratory instruments and workflow solutions. The company offers a broad product suite, including silicone thickness and distribution analyzers, configurable benchtop workflow solutions, biologics quantification and quality combos, protein and nucleic acid quantification systems, stability screening and aggregation characterization platforms, protein sizing systems, chemical and elemental particle identification platforms, and customizable automated workflow solutions. Led by Founder and CEO Tim Harkness, Unchained Labs supports biologics research through both instruments and automated workflows. Financially, the company has raised $86m in equity over the prior four years from Novo Ventures, Canaan Partners, TPG Biotech and Tri-Valley Ventures. It recently closed a $50m debt facility to improve its capital structure. The company intends to use the proceeds to support working capital growth and to add dry powder for future acquisitions. Unchained Labs is a Pleasanton, CA–based life sciences company led by founder and CEO Tim Harkness. The company offers eight product lines and direct distribution around the world. It has grown to over 130 employees and generates more than $35M in revenue. Unchained Labs has pursued an acquisition-driven expansion, completing five acquisitions in just over two years, most recently buying Trinean. Trinean's DropSense systems measure protein, DNA and RNA concentration in biologics and genomics samples; the acquired company is led by CEO Philippe Stas. Unchained Labs develops laboratory instruments and platforms for measuring protein stability parameters. The company acquired Optim, a multiplex protein stability platform for biologics, from The Avacta Group; Optim measures denaturing temperature and aggregation onset temperature on multiple samples simultaneously. Over 60 Optim platforms have been sold to biopharma and academic customers worldwide. The company is led by founder and CEO Tim Harkness. Unchained Labs plans to continue acquiring businesses and product lines to develop and commercialize additional products. The article does not disclose revenue or other financial metrics beyond the fundraise.

Total raised

$88M

Funding rounds

3

Latest round

Debt Financing

Latest activity

May 2019